Background: Fibrin glue has widespread use in multiple fields of surgery. There have been numerous studies on the use of fibrin glue in facelifts, with no consensus regarding differences in outcomes. Objectives: This study compared the risk of hematoma, seroma, and the 24-hour drainage volume in all published prospective controlled trials. Methods: A MEDLINE search of English-language articles on fibrin glue and rhytidectomy published up to July 2013 yielded 49 citations. After screening, we examined 7 relevant controlled trials. The DerSimonian and Laird random-effects model was used to perform the meta-analysis. Results: Seven controlled trials measuring the outcomes of fibrin glue in facelifts were used to estimate the pooled relative risk of complications and confidence intervals. Hematoma formation was four times less likely with the use of fibrin glue (relative risk 0.25, P = .002). There was no significant reduction in seroma formation (relative risk 0.56, P = .19). There was not enough data to properly measure 24-hour drainage and ecchymoses. Conclusions: This analysis suggests that fibrin glue reduces the rates of hematoma formation, but does not significantly reduce the rates of seroma development.
While facelifts are generally considered to be a safe and effective procedure, hematoma is the most likely major complication, as a result of the large surface area created beneath the flaps. The rate of hematoma formation varies significantly; it has been cited to be as low as 1.86% and as high as 9%. 1 Hematomas, especially large ones, can lead to tissue necrosis, prolonged recovery from edema and ecchymoses, hyperpigmentation, and reduced patient satisfaction. There have been many attempts, with varying rates of success, to reduce the rate of hematoma after rhytidectomies, including by using drains and autologous platelet-rich plasma. Fibrin tissue adhesive, or fibrin glue, has been an area of interest for reducing hematoma, but the data in the literature have been inconsistent to date.
Fibrin glue is composed primarily of fibrinogen derived from human plasma. In the application device, the fibrinogen is activated by thrombin and stabilized by factor XIII to facilitate clot formation. Additionally, many formations also contain aprotinin, a substance which prevents the body's natural clot lysis process. The fibrin clot reduces postoperative bleeding by adhering adjacent surfaces to each other, in addition to restricting capillary flow.
Since its first use in 1972 in the United States, fibrin glue has been utilized in many procedures, such as posthyroidectomy wound management, breast surgery, and spinal cord surgery. However, due to relatively low sample sizes in randomized controlled trials, the literature on its use in rhytidectomies has been inconclusive. Various authors have conducted trials to investigate the efficacy of tissue glues in rhytidectomies, with mixed results. Marchac and Greensmith recommended against its use based on their findings in their 2005 trial. 3 Prior to 2013, no studies found significant reductions in the incidence of hematoma formation. However, some trials showed improvements in ecchymoses, seroma, and drainage rates. [3] [4] [5] [6] [7] [8] [9] A meta-analysis was performed by Por et al., and found that there were no statistically significant differences in any outcome measures. 10 While this effort was laudable and provided important information, there is room for improvement because of the small number of studies published at that time. To update and improve upon the previous study's effort, the authors conducted a meta-analysis to determine the efficacy of fibrin glue in reducing hematoma formation, seroma formation, 24-hour drainage, and ecchymoses in deep-plane rhytidectomies.
METHODS
A PubMed search of the MEDLINE, EMBASE, and Cochrane databases was performed independently by two of the authors with a cut-off date of July 9, 2013, to identify all randomized, controlled trials published at that time. The search terms "rhytidectomy AND platelet rich plasma," "face lift AND platelet rich plasma," "rhytidectomy AND fibrin glue," "facelift AND fibrin glue," "tissue glue AND facelift," and "tissue glue AND rhytidectomy" were used to create the list of applicable trials. The reference lists of relevant studies were also manually reviewed for additional sources. Abstracts and articles were read to determine eligibility.
Only clinical trials were included for analysis. The data was extracted from the articles independently by two authors, and discrepancies were resolved by consensus. Hematoma formation rates were the primary outcome, while incidences of seroma, 24-hour drainage volume, and ecchymoses at one day post-operation were secondary outcomes.
For statistical analyses, relative risk was estimated from rate ratios, and 95 percent confidence intervals were created from the original data. Without regard to P-value for heterogeneity, the DerSimonian and Laird random effects method was used to measure between-study and within-study variability. 11 Forest plots were generated from the results. All calculations were performed with Stata 12.0 software (Stata Corp., College Station, TX).
RESULTS
The initial search retrieved 49 articles. After screening abstracts and articles, 42 articles were excluded for not meeting the criteria. They were mostly retrospectives, reviews, and case studies. Of the seven studies included in our analysis, six measured rates of hematoma and seroma. Ecchymoses was measured in three of the studies, but without a provided standard deviation no statistical analysis could be performed. Of the four studies that measured 24-hour drainage, only two provided the standard deviation. A total of 327 sides of faces received fibrin glue treatment and 327 sides of faces received standard-of-care treatment. Details regarding the publications included in the meta-analysis are contained in Table 1 . [3] [4] [5] [6] [7] [8] [9] The DerSimonian and Laird random effects method showed that there was a statistically significant reduction in hematoma with the use of fibrin glue (relative risk 0.25, P = .002; Table 2 and Figure 1 ). The Forest plot showed the relative risk and 95% confidence interval for each study and the percent of weight of each study that contributed to the overall result. There was no significant difference in occurrence of seroma (relative risk 0.56, P = .19; Table 3 and Figure 2 ). In the two studies that included adequate information on 24-hour drainage, there was a significant reduction in drainage (P < .001; Table 4 and Figure 3 ). There was inadequate information to measure ecchymoses.
One of the studies was found to have a very high rate of hematoma (16%), while another study had very low numbers (N = 9). 7, 8 Although power was introduced through the statistical models used, we felt that the results of the study could be stated with more certainty if the results of these two studies were excluded. When this data was excluded, the results for hematoma were consistent, with a decreased rate of hematoma found with the use of glue (P = .046; Figure 4 and Table 5 ).
DISCUSSION
This meta-analysis found that sides of faces treated with fibrin glue were four times less likely to develop hematoma as ones treated with standard care (relative risk 0.25, P = .002). When the data were analyzed, the statistical analysis was re-done with omission of data from one study with an extraordinarily high rate of hematoma, and from another study with a very small set of patients. 7, 8 After re-analyzing the data with this arguably more precise subset of results, the decrease in hematoma rate with fibrin glue was still found. Hematoma formation was selected as the primary outcome measure for this study, as it is the most frequent complication of a rhytidectomy. It must be noted that "hematoma" can mean either a small collection of blood easily drained in the office, or an emergent bleed that warrants a return to the operating room. Naturally, the latter is a much more serious complication, but most of the manuscripts did not address this difference. The Marchac paper mentioned that the one hematoma noted was serious enough for a return to the operating room. 3 In the report by Kamer and Nguyen, hematomas were broken down into "localized" and "expanding." 6 These numbers were both included in the analysis as hematoma complications. Although hematoma was the primary focus of this systematic analysis, a trend was also noted towards reductions in seroma; however, it was not of statistical significance (relative risk 0.56, P = .19). The secondary objective in measuring ecchymoses was abandoned, as they were only noted in the studies by Hester et al., Lee et al., and Fezza et al., and none reported standard deviations. 5, [7] [8] [9] Because of their clinical effectiveness and rapidly expanding commercial availability, fibrin glues have become prevalent in nearly every surgical field. There have been over 2300 published reports in the surgical literature. 12 Likewise, fibrin glue has become increasingly popular in facial aesthetic surgery. There have been promising reports on the use of fibrin glue in lower transcutaneous blepharoplasty and endoscopic brow lifts. 13, 14 Fibrin glue sealants are used extensively throughout surgery to augment hemostatis. To fully understand the glue's mechanism of action, it is important to understand the coagulation cascade. In the final steps of the cascade, fibrinogen and factor XIII are activated by thrombin. The fibrin molecules form a polymer that is then strengthened by factor XIII, which initiates fibrin crosslinking. Fibrin glue facilitates these interactions by creating an environment that optimizes the interaction of these proteins. The delivery device contains two components. The first is fibrinogen and factor XIII, as well as other facilitative plasma proteins. The second major component is thrombin, which is often pooled with calcium chloride and aprotinin, a protein that prevents fibrinolysis, prolonging the eventual breakdown of the material. Fibrin-derived adhesives have the distinct benefit over synthetic adhesives of being reabsorbable and biocompatible. Traditionally, fibrin glue has been derived via autologous or homologous plasma purification, although synthetic fibrin sealants have been introduced commercially and have been included in this meta-analysis. There are few side effects: mostly allergic reactions and the theoretical fear of transmitting infectious disease in homologous-derived forms.
Retrospective studies showed favorable results for fibrin glue in reducing the incidence of hematoma in rhytidectomy Heterogeneity chi-squared = 1.89 (d.f. = 5), P = .864. Test of RR = 1: z = 3.08, P = .002. patients. Zoumalan and Rizk found that only 0.4% of their patients who received fibrin glue developed hematomas, compared to 3.4% of patients who did not receive fibrin glue. 15 Marchac and Sandor found similar results in retrospectively examining 200 of their fibrin glue rhytidectomy patients. 16 However, Jones and Grover found no benefit of fibrin glue in a review of 910 of their patients. 1 These conflicting retrospective studies called for the randomized, controlled trials that we examined in this meta-analysis.
A previous meta-analysis by Por et al. found no statistical difference in the incidence of hematoma development in patients who received fibrin glue. 10 The authors only included two fibrin glue trials (Marchac and Greensmith 3 and Oliver et al. 4 ) and one on platelet-rich plasma trial. They found a trend towards reduction in ecchymoses and wound-drainage formation, but pooled analyses in their Forest plots crossed the line of no effect, showing no significance. Since then, multiple studies have been published with large enough sample sizes to call for a new metaanalysis. In this project, Forest plots were chosen, as in other meta-analyses, including the Por study. A Forest plot is a method for graphical display used to demonstrate the relative effects of treatments in multiple quantitative scientific studies addressing the same question. This makes them perfect for meta-analyses such as this one.
Oliver et al. conducted the first trial of fibrin glue in rhytidectomy, but only measured the median 24-hour drainage. 4 They found a significant reduction in volume of the drainage (10 mL vs 30 mL), but they only reported the interquartile range and not the standard deviation, which is needed for comparison of means tests. Consequently, this trial was not included in any of the analyses.
Fezza et al. found a non-significant reduction in hematoma, but found an interesting 13.3 minute reduction in operating time.
5 This is likely due to less time spent obtaining hemostasis. As an editorial side note, the authors strongly recommend absolute attentiveness to hemostasis, and these glues cannot be considered a replacement for meticulous hemostasis.
Marchac and Greensmith found what they considered evidence against the efficacy of fibrin glue in finding drainage rates that were statistically different at 26 mL and 33.5 mL, but with results that they did not consider clinically significant. 3 They concluded that fibrin glue was not costeffective compared to drains alone. They also did not provide the standard deviation, so their drainage rates were not included in this analysis.
Using drains after rhytidectomy has never been shown to decrease the rate of hematoma, although it is arguable that their use may allow an earlier and more confident Hester et al. diagnosis. Jones has extensively studied the occurrence of hematoma after rhytidectomy, and he demonstrated that drains are associated with decreased ecchymosis, but not a decrease in the rate of hematoma. 17 It must be pointed out that he has also seen the formation of soft tissue tracks around drainage tubes, and that this is something to consider when deciding upon their use.
The two major trials released after the previous metaanalysis by Por et al. are the phase 2 and phase 3 clinical trials by Hester et al. in 2013. 8, 9 These trials had relatively large sample sizes (n = 45 and 75, respectively) and contributed to the power of our analysis. They are also the only studies that provided standard deviations for the 24-hour drainage. Another study included in our analysis was a trial of 9 patients by Lee et al., which was limited by its small sample size but was included in our calculations for hematoma. 7 They used blinded observers to rate ecchymoses on a scale from 1 to 10. The untreated average was 6.2, while the treated average was 4.5.
7
Because of the unusually high rate of hematoma (16%) reported in the Hester trial, and the small sample size of the Lee study, these two studies were excluded from the analysis to see if the results were still statistically significant. 7, 8 When this was done, the same results were found: the use of tissue glues in rhytidectomy lead to a lower rate of hematoma, with a P value of 0.046 ( Figure 4 and Table 5 ).
In this investigation, some of the included studies used half-face models, where the patient's contralateral side served as its own control; in others, patients were randomized into groups where tissue glues were either used or not used. This is another weakness of a retrospective systematic review or meta-analysis, where different investigative models are used. Another weakness of this study is that there was not one type of tissue glue used consistently throughout the papers analyzed through this effort. Different authors used Beriplast (CSL Behring, Kankakee, IL), Crosseal ( Johnson & Johnson, New Brunswick, NJ), and Tisseel (Baxter, Deerfield, IL), while some studies did not specify the glue used. This is inherent within any meta-analysis of this type, especially within the field of plastic surgery.
Another weakness that must be addressed is the fact that no facelift technique (or individual patient's facelift operation, for that matter) is the same. There is a different amount of undermining done with each surgeon's different technique, and in each individual patient.
If one of the surgeons had an extensive amount of skin undermining, his hematoma rate may be higher; in another study, if the amount of undermining is less, the rate may be lower. The variation in technique is a major limiting factor in comparing studies such as these.
No discussion of the use of tissue glues in cosmetic surgery would be complete without alluding to their cost. Because these are out-of-pocket operations, cost is a sensitive issue for some patients. A true cost-benefit analysis is beyond the scope of this paper, but each surgeon would benefit from examining their hematoma rates and what the hard costs are for them and their patients in the setting in which they work (office vs. surgery center vs. hospital). Using the numbers reported in the papers discussed here and studying one's own practice could be enlightening to individual readers. Careful attention was taken to avoid trials on plateletrich plasma and to only include randomized, controlled trials on fibrin glue. Platelet-rich plasma is a concentration of platelets and fibrinogen formed by centrifuging autologous blood. Compared to fibrin glue, platelet-rich plasma has a much higher concentration of platelets and a lower concentration of fibrinogen. It accelerates clot formation, much like fibrin glue, but its main usage is for the angiogenic growth factors released by the platelets rather than as a hemostatic adjunct. 18 The senior authors of this metaanalysis use autologous, platelet-rich plasma as a spray to facilitate quicker healing and decreased inflammation, not for the purposes of hemostasis. Over a 15-year period, this appears to have led to reduced swelling, bruising, and recovery time. One might theorize that tissue adherence may inhibit or reduce the immediate tissue response to injury. However, this is anecdotal, opinion-based evidence, and must be investigated further.
CONCLUSION
The findings of this meta-analysis reveal that the use of fibrin glue in facelifts reduces the risk of hematoma when compared to standard treatment. Hematoma is the most frequent cause of morbidity and patient dissatisfaction with facelifts. Like many prospective studies in aesthetic surgery, the trials on fibrin glue in rhytidectomies have generally had small sample sizes, which is why this meta-analysis was important. The only previous meta-analysis lacked adequately large studies to draw statistically significant conclusions. This meta-analysis confirms the promising usage of fibrin glue in reducing complications, particularly those related to hematoma.
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